Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
出版年份 2021 全文链接
标题
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate Cancer
作者
关键词
-
出版物
JAMA Network Open
Volume 4, Issue 3, Pages e2037657
出版商
American Medical Association (AMA)
发表日期
2021-03-12
DOI
10.1001/jamanetworkopen.2020.37657
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
- (2020) Michael Ahdoot et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Four-Kallikrein Panel Is Effective in Identifying Aggressive Prostate Cancer in a Multiethnic Population
- (2020) Burcu F. Darst et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
- (2019) Tom Callender et al. PLOS MEDICINE
- Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)
- (2018) Rita Faria et al. EUROPEAN UROLOGY
- Screening for Prostate Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
- (2018) Tyler M Seibert et al. BMJ-British Medical Journal
- Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts
- (2018) Tyler M Seibert et al. BMJ-British Medical Journal
- Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer
- (2018) Nora Pashayan et al. JAMA Oncology
- Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
- (2018) Dragan Ilic et al. BMJ-British Medical Journal
- Germline variation at 8q24 and prostate cancer risk in men of European ancestry
- (2018) Marco Matejcic et al. Nature Communications
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
- (2016) Jeffrey C. Weinreb et al. EUROPEAN UROLOGY
- 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
- (2016) Freddie C. Hamdy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
- (2015) Nora Pashayan et al. GENETICS IN MEDICINE
- Estimating the cost of caring for people with cancer at the end of life: A modelling study
- (2015) Jeff Round et al. PALLIATIVE MEDICINE
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- Quality-of-Life Effects of Prostate-Specific Antigen Screening
- (2012) Eveline A.M. Heijnsdijk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Using Health State Utility Values from the General Population to Approximate Baselines in Decision Analytic Models when Condition-Specific Data are Not Available
- (2011) Roberta Ara et al. VALUE IN HEALTH
- Mean sojourn time, overdiagnosis and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
- (2009) N Pashayan et al. BRITISH JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now